SOPHIE is brought to you by Innovation Factory

Innovative Health Diagnostics and AIMA Laboratories Collaborate to Develop New, Revolutionary At-Home Test to Detect Endometriosis

ORIGINAL PRESS RELEASE, Nicole Estrin, Innovative Health Diagnostics, August 16, 2022

Both laboratories join forces to expand access to an important and reliable endometriosis blood test that can be self-administered anytime, anywhere

Innovative Health Diagnostics (IHD), a CLIA- and FDA-certified lab that empowers every person by providing access to accurate, clinical testing, announced today a new partnership with AIMA Laboratories (AIMA), a preclinical FemTech company dedicated to developing new products that fill current gaps in gynecological health, to develop and deliver a new and reliable at-home blood test to detect endometriosis.

“At AIMA, our mission is to shorten a woman’s path to a healthier tomorrow”

Endometriosis is a disease where tissue similar to the lining of the uterus grows outside the uterus, causing pain and/or infertility. For the roughly 10% of reproductive age women and girls globally who have endometriosis – approximately 190 million – there is a significant gap between when symptoms first appear and when they are diagnosed, which can typically take around 5 to 12 years.

Learn more about Innovation Factory client: AIMA Laboratories.

Share this article